U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Too Few People Treated for Hepatitis C: Reducing Barriers Can Increase Treatment and Save Lives: CDC Vital Signs: Aug. 9, 2022

Supporting Files Public Domain
File Language:
English


Details

  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication.
  • Description:
    Over 2 million adults in the United States have hepatitis C virus (HCV) infection, and new infections have continued to rise. Hepatitis C is usually spread through blood, often from injection drug use. Left untreated, hepatitis C can cause advanced liver disease, liver cancer, and death. In 2019, hepatitis C contributed to the deaths of more than 14,200 people in the United States; deaths associated with hepatitis C were higher for Black people (5 per 100,000) and Hispanic people (4 per 100,000) than for White people (3 per 100,000).

    Hepatitis C is curable in more than 95% of cases. People who test positive for hepatitis C should be treated with direct-acting antiviral (DAA) medication. Timely treatment is important to prevent liver damage and further spread. Treatment saves lives, prevents ongoing spread, and can save costs by stopping the disease from progressing.

    Safe and effective medications (DAAs) for hepatitis C have been available since 2014, yet few people receive treatment within one year of diagnosis. Expanding treatment for all people with hepatitis C is essential to reducing viral hepatitis-related disparities and eliminating hepatitis C as a national public health threat. Too many barriers to treatment remain, including getting diagnosed, being linked to care, and accessing treatment. Even among insured people, only about 1 in 3 receive timely hepatitis C treatment, and this is even lower among people with Medicaid insurance.

  • Subjects:
  • Series:
    Vital Signs
  • Document Type:
    Text
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:15a9d5e608b266509ddb0ce29002a3008b5666c9d9653772d924857ee9c34b9b73fad1c40c1a7f49dd9c94cc36d355bbeb1ae6901cbd33e97662259b66b3f70b
  • Download URL:
  • File Type:
    Filetype[PDF - 1.92 MB ]

Supporting Files

PREVIOUS
File Language:
English
ON THIS PAGE
Details Supporting Files
 Was this page helpful?
 Found an issue?
Send us an email at:
publishinghd@cdc.gov
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
BACK TO TOP